These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3151089)

  • 1. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-dependent chemotherapy of schistosomiasis.
    Fallon PG; Cooper RO; Probert AJ; Doenhoff MJ
    Parasitology; 1992; 105 Suppl():S41-8. PubMed ID: 1308928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hycanthone and praziquantel on monoamine oxidase and cholinesterases in Schistosoma mansoni.
    Kim RA; Lukacs J; Tanaka RD; MacInnis AJ
    J Parasitol; 1981 Feb; 67(1):20-3. PubMed ID: 7229816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
    Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
    Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune-dependence of chemotherapy in experimental schistosomiasis.
    Doenhoff MJ
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():31-7. PubMed ID: 2517867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the mode of antischistosomal action of hycanthone.
    Cioli D; Pica-Mattoccia L; Rosenberg S; Archer S
    Life Sci; 1985 Jul; 37(2):161-7. PubMed ID: 4010473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
    Allam G; Eweas AF; Abuelsaad AS
    Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
    Brindley PJ; Strand M; Norden AP; Sher A
    Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
    Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic properties of the antischistosomal drug hycanthone.
    Hillman GR; Senft AW
    Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic change associated with the development of resistance to hycanthone in Schistosoma mansoni.
    Brindley PJ; Lewis FA; McCutchan TF; Bueding E; Sher A
    Mol Biochem Parasitol; 1989 Oct; 36(3):243-52. PubMed ID: 2571929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of praziquantel versus hycanthone on deoxyribonucleic acid content of hepatocytes in murine schistosomiasis mansoni.
    Botros SS
    Pharmacol Res; 1990; 22(2):219-29. PubMed ID: 2109860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic analysis of hycanthone resistance in Schistosoma mansoni.
    Cioli D; Pica Mattoccia L
    Am J Trop Med Hyg; 1984 Jan; 33(1):80-8. PubMed ID: 6696189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory induced resistance to praziquantel in experimental schistosomiasis.
    Ismail MM; Taha SA; Farghaly AM; el-Azony AS
    J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.